Skip to content Black November30% on all gummies

Blog Sleep & Relaxation

Best ashwagandha gummies: extract, dose and how to choose

There is no single 'best ashwagandha gummy' that the evidence allows us to point to, and anyone who promises you otherwise is going beyond what is known.

  • 12 min read

There is no single 'best ashwagandha gummy' that the evidence allows us to point to, and anyone who promises you otherwise is going beyond what is known. What you can do is choose using criteria: extract from the root, an amount of extract per daily serving close to the range used in trials (about 300 to 600 mg per day), standardisation declared on the label and an ingredient list without surprises.1 Before that, be aware that European authorities do not consider it risk-free: Denmark prohibits its sale in supplements, and the agencies in Germany and the Netherlands advise against consumption for several groups of people.2,3,4

This guide does not rank brands: we have not tested third-party products. It shows you how to read any label and where our gummies stand against the same criteria.

Quick verdict: what to check in an ashwagandha gummy

  • Plant part: root, stated explicitly. Leaves and root have different compositions.3
  • Extract: ideally with the extraction ratio and the withanolide content (the standardised %).
  • Dose: milligrams of extract per daily serving, not per gummy. The most cited trials used 300 to 600 mg per day, and some effects reported for sleep appear only at 600 mg or more.1,5
  • The rest of the gummy: other actives in the same serving make evaluation harder.3
  • Sugar and polyols: read the nutrition table, especially if you are going to take it every day.
  • Cost: compare the price per daily serving and the amount of extract you receive.
  • For you: pregnancy, breastfeeding, liver or thyroid disease and certain medicines are reasons not to take it.3,4

How we evaluate: transparent criteria, the same for all brands

1. Is it root or leaf?

Traditionally the root is used, but products containing leaves have appeared in Europe. The German Federal Institute for Risk Assessment (BfR) notes that the plant part and the extraction process influence the concentration of the active compounds.3 If the label does not say which part the extract comes from, you cannot compare it with the trials.

2. Is the extract standardised?

The compounds most associated with the plant are withanolides. A standardised extract declares its percentage; without that information, compositions can vary greatly from brand to brand. According to the BfR, current data do not even allow us to say with certainty which substances and doses explain the effects described in studies.3 Declared standardisation is a sign of transparency, not a guarantee of efficacy.

3. How many milligrams of extract per day?

In a meta-analysis of 12 randomised trials, the dose-response analysis indicated a favourable effect on stress scores at 300 to 600 mg per day.1 In another meta-analysis, of trials on sleep, the effects were more marked at doses of 600 mg per day or more and with treatments of eight weeks or more.5 Always check the amount per daily serving and how many gummies make up that serving.

4. What else is in the gummy?

Many gummies combine ashwagandha with other substances. The BfR stresses that combination products make it harder to draw conclusions about the cause of each effect.3 The more actives there are, the harder it is to know what to attribute what you feel to, good or bad.

5. Sugar and polyols

A gummy with sugar adds sugar every day. Those that use polyols (such as maltitol) have less, but excessive consumption of polyols may have a laxative effect.

6. Cost per effective dose

Divide the pack price by the number of daily servings and compare only products with similar amounts of extract.

What the research showed, and what it did not show

In terms of claims, the situation is simple: there is no authorised EU health claim for ashwagandha. Claims relating to botanical substances are still under consideration by the European Commission and are not listed as authorised.6 A European label or advertisement cannot legitimately promise less stress, better sleep or lower cortisol because of ashwagandha. See also ashwagandha: benefits and what the science says.

There is research, and this is what it reports, with its limitations:

  • Stress and anxiety in questionnaires. A meta-analysis of 12 randomised trials, with 1002 participants, reported lower scores on stress and anxiety scales in the groups that took extract, compared with placebo. The authors classify the certainty of the evidence as low, with very high heterogeneity between studies.1
  • Sleep. A meta-analysis of five trials, with 400 participants, found a small effect on global sleep measures. The authors note that data on serious adverse effects are limited and that more safety data would be needed for prolonged use.5
  • Safety. According to the BfR, the studies mainly assessed possible benefits; undesirable effects were not recorded systematically and long-term use is poorly studied.3

There are trial results, but that does not amount to an effect demonstrated and safe for everyone: the BfR states that the effects promised by manufacturers are not scientifically proven.3 On doses, see ashwagandha: daily dose.

Gummies or capsules: the practical differences

A capsule can contain 300 to 600 mg of extract without sugar or sweetener. A gummy shares its space with the gelling agent and the sweetener, so higher doses require more gummies per day. On the other hand, it is easy to carry and to stick with, and some people prefer not to swallow capsules. The legitimate doubt concerns the studies: we are not aware of trials of ashwagandha specifically in gummy form. The full comparison is in ashwagandha gummy or tablet.

Our ashwagandha gummies, in the light of these criteria

We apply the same criteria to TuttiBear's Stress Relief Gummies, using only the label data:

  • Declared dose: 300 mg of ashwagandha extract per daily serving of 2 gummies. This is at the lower limit of the 300 to 600 mg range used in trials and below the 600 mg mentioned in the sleep results.
  • Standardisation: the label does not state the plant part, the extraction ratio or the withanolide percentage. Standardisation cannot be verified from the label, and so we cannot say that it corresponds to the extract of any particular study.
  • Combination: the same serving contains 100 mg of L-theanine, 100 mg of GABA, 25 microgram of vitamin D3 and 500 microgram of vitamin B12. It is a combination product, with the evaluation limitation that the BfR describes.3 On the other actives, see L-theanine: benefits.
  • Vitamins: vitamin D3 and vitamin B12 are present in amounts exceeding 15% of the reference values (500% and 20 000%, respectively). Authorised claims can therefore be used, such as 'vitamin B12 contributes to normal functioning of the nervous system', 'vitamin B12 contributes to the reduction of tiredness and fatigue' and 'vitamin D contributes to the maintenance of normal bones'.7 They relate to the vitamins, not to ashwagandha.
  • Sugar, sweetener and gelling agent: 0 g of sugars and 8 kcal per serving; maltitol as sweetener and pectin as gelling agent. The label warns that excessive consumption of polyols may have a laxative effect.
  • Packaging: 60 gummies (180 g), that is, 30 daily servings. The current price is on the product card on this page.

10% off to get you started ✨

Subscribe to our newsletter and receive your welcome code straight away. Get updates, tips and exclusive offers.

By subscribing, you agree to receive marketing communications from Tutti Bear. You can unsubscribe at any time. Please see our Privacy Policy and Terms and Conditions .

In short: they declare the amount of extract and contain no sugars, but they do not say which part of the plant the extract comes from or how it is standardised, and the dose is at the lower limit of the studied range.

Who should not take ashwagandha

This is the most important section of this guide. The position of several European authorities is considerably more restrictive than marketing suggests.

What the European authorities say

  • Denmark: the Danish Food Safety Authority (Fødevarestyrelsen) states that it is illegal to sell products containing ashwagandha in Denmark, based on a risk assessment by the Technical University of Denmark (DTU), which refers to negative effects on sex hormones and reproduction.2 We were unable to open the DTU report; according to the RIVM summary, the DTU was unable to establish a safe level of use.4
  • Germany: in September 2024, the BfR recommended that children, pregnant women, breastfeeding women and people with current or past liver disease should not take ashwagandha preparations, and advised restraint for other adults. This is not a ban, and the BfR makes clear that it was not possible to derive a safe intake amount.3
  • Netherlands: in 2024, the public health institute RIVM advised consumers, as a precaution, not to use ashwagandha preparations, especially during pregnancy. This is also not a ban.4

Liver, thyroid and pregnancy

Liver. A series of five cases of liver injury attributed to ashwagandha supplements was published, in Iceland and the United States. All developed jaundice 2 to 12 weeks after starting to take it, and liver tests normalised within one to five months in four of the five.8 The RIVM counted nine case reports (seven of liver injury, one of thyrotoxicosis and one of adrenal suppression) and four notifications to the Dutch pharmacovigilance centre, stressing that case reports do not prove causality.4 The BfR recommends that anyone who has or has had liver disease should not take it.3

Thyroid. The RIVM refers to indications, in animal and human studies, that the plant may alter thyroid hormones and cause hyperactivity of the gland. It also refers to possible interactions with antidiabetic medicines and thyroid hormones.4 The BfR also mentions possible interactions with blood pressure medicines and immunosuppressants.3 The label of our gummies does not recommend the product for people with thyroid or autoimmune diseases.

Pregnancy and breastfeeding. Safety data are lacking and the plant has historically been used to induce abortion, according to the WHO cited by the RIVM. Pregnant and breastfeeding women should therefore not take it.4,3 The same applies to children.

Other cases. If you take regular medication, speak to your doctor or pharmacist first. As the label warns that the gummies may cause drowsiness, take care when driving and speak to a healthcare professional if you take medicines that also cause drowsiness. Stop and seek medical help if you experience jaundice (yellowing of the skin or eyes), dark urine, intense itching or persistent nausea.8 See also is ashwagandha bad for you?

How to take it, if you decide to

  • Follow the label dose. For our gummies, that is 2 gummies per day, preferably after a meal, without exceeding the recommended daily dose.
  • Do not stack several ashwagandha supplements.
  • Give it time, but set a limit. The most favourable trials lasted eight weeks or more.5 As the effects of prolonged use are poorly studied, it is worth reassessing with a healthcare professional rather than taking it indefinitely.3
  • Stop if warning signs appear: drowsiness, digestive discomfort or the symptoms above.

On timing, see ashwagandha: morning or night; more topics in sleep and relaxation.

Common mistakes when choosing ashwagandha gummies

  • Assuming that 'natural' means safe. Herbal supplements do not go through an authorisation that assesses safety before they reach the market; the responsibility lies with the operator.3
  • Confusing 'extract' with 'standardised extract'. Without the plant part or the % of withanolides, you do not know what you are comparing.
  • Comparing price per pack. The same price can hide very different amounts of extract.
  • Believing health promises. No health claim is authorised for ashwagandha in the EU; be suspicious of anyone promising results.6
  • Expecting rapid effects. The studies assessed outcomes after weeks.5

In summary

There are no demonstrable 'best ashwagandha gummies'. There are labels that are more transparent than others: root stated, declared standardised extract, milligrams per daily serving close to the studied range, a simple ingredient list and clear information on sugars and polyols. Even so, it remains a supplement with no authorised health claim for ashwagandha, with warnings from European authorities and published cases of liver injury. If you have doubts, are in a risk group or take medicines, speak to a healthcare professional first.

Frequently asked questions

Which is the best ashwagandha gummy?

There is none that the evidence allows us to identify as the best. Compare labels: root extract, amount of extract per daily serving close to 300 to 600 mg, declared standardisation, few additional ingredients and clear information on sugars and polyols. Before choosing, check that you are not in a group for which the authorities advise against ashwagandha.

How many milligrams of extract should an ashwagandha gummy contain?

The most cited trials used about 300 to 600 mg of extract per day. What counts is the amount per daily serving, not per gummy, so check how many gummies make up the serving. Higher doses are not demonstrated to be safer.

Do ashwagandha gummies work?

There is no authorised EU health claim for ashwagandha. Meta-analyses of trials report results on stress and sleep questionnaires, but with low certainty of evidence and limited safety data. We are also not aware of trials carried out specifically with gummies.

Is ashwagandha banned in Europe?

Not throughout Europe. Denmark states that the sale of products containing ashwagandha is illegal. Germany (BfR) and the Netherlands (RIVM) have issued precautionary recommendations, but not bans.

Can I take ashwagandha if I have thyroid problems or take medication?

Speak to your doctor first. There are indications that ashwagandha may alter thyroid hormones and possible interactions with medicines such as antidiabetics, blood pressure medicines and immunosuppressants. The label of our gummies does not recommend the product for people with thyroid or autoimmune diseases.

Is root or leaf extract better?

Trials and traditional use focus mainly on the root, and the composition varies with the plant part and the extraction method. The label should therefore state the part used. If it does not, you cannot compare the product with the studies.

Who should not take ashwagandha gummies?

Children, pregnant women, breastfeeding women and people with current or past liver disease should not take them, according to the BfR. Anyone with thyroid or autoimmune disease, or taking regular medication, should speak to a healthcare professional first. Stop and seek medical help if jaundice, dark urine or intense itching occurs.

Sources and references

Editorial buying guide. The criteria apply to any brand; the TuttiBear gummy data come from the product label. We have not tested third-party products and we do not publish brand rankings. Sensitive subject: the position of the European authorities on ashwagandha was verified in November 2026 and should be reviewed periodically.

  1. Akhgarjand C, Asoudeh F, Bagheri A, Kalantar Z, Vahabi Z, Shab-Bidar S, et al. Does ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022;36(11):4115-24. pubmed.ncbi.nlm.nih.gov · PMID 36017529 · DOI 10.1002/ptr.7598
  2. Fødevarestyrelsen (Danish Veterinary and Food Administration). Ashwagandha i kosttilskud og drikkevarer [Internet]. [cited 2026 Nov 12]. foedevarestyrelsen.dk
  3. Bundesinstitut für Risikobewertung (BfR). Ashwagandha: Schlafbeeren-Präparate mit möglichen Gesundheitsrisiken. Mitteilung Nr. 039/2024. Berlin: BfR; 2024 Sep 10. bfr.bund.de
  4. de Heer JA. Risk assessment of herbal preparations containing Withania somnifera (Ashwagandha). RIVM letter report 2024-0029. Bilthoven: National Institute for Public Health and the Environment (RIVM); 2024. rivm.nl · DOI 10.21945/RIVM-2024-0029
  5. Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. Effect of ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One. 2021;16(9):e0257843. pubmed.ncbi.nlm.nih.gov · PMID 34559859 · DOI 10.1371/journal.pone.0257843
  6. European Commission. EU Register of nutrition and health claims made on foods [Internet]. Brussels: European Commission; [cited 2026 Nov 12]. food.ec.europa.eu
  7. Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health. Annex (text consulted at legislation.gov.uk). legislation.gov.uk
  8. Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-9. pubmed.ncbi.nlm.nih.gov · PMID 31991029 · DOI 10.1111/liv.14393

Keep exploring

This article is for information only and does not replace medical advice. Talk to your doctor or pharmacist before taking a supplement, especially if you take medication or have a health condition.

Explore the topic

Explore the topic

Related reads

Related reads

10% off your first order

Subscribe and get your welcome code, plus updates, routines and exclusive offers — straight to your inbox.

Country & Language

Please select your country and language:

Country

Language